Work

Lichen Sclerosus: An autoimmunopathogenic and genomic enigma with emerging genetic and immune targets

Year: 2019
Type: review
Abstract: Lichen sclerosus (LS) is an inflammatory dermatosis with a predilection for anogenital skin.Developing lesions lead to vulvar pain and sexual dysfunction, with a significant loss of structural anatomical architecture, sclerosis, and increased risk of malignancy.Onset may occur at any age in both sexes, but typically affects more females than males, presenting in a bimodal fashion among pre-pubertal children and middle-aged adults.A definitive cure remains elusive as the exact pathogenesis of LS remains unknown.A general review of LS, histologic challenges, along with amounting support for LS as an autoimmune disease with preference for a Th1 immune response against a genetic background is summarized.In addition to the classically referenced ECM1 (extracellular matrix protein 1), a following discussion of other immune and genetic targets more recently implicated as causative or accelerant agents of disease, particularly miR-155, downstream targets of ECM1, galectin-7, p53, and epigenetic modifications to CDKN2A, are addressed from the viewpoint of their involvement in three different, but interconnected aspects of LS pathology.Collectively, these emerging targets serve not only as inherently potential therapeutic targets for treatment, but may also provide further insight into this debilitating and cryptic disease.
Language: English
Subfield: Surgery
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W2951860220
FWCI: 3.046
Cites: 102
Cited by: 196
Related to: 10